First-Line Treatment for Phantom Limb Pain

Primary Treatment Options

The American College of Physicians recommends anticonvulsants, such as gabapentin, as a first-line treatment for phantom limb pain, with a starting dose of 100-300 mg at bedtime and gradual titration to 900-3600 mg/day in 2-3 divided doses 1
The International Association for the Study of Pain consensus panel recommends anticonvulsants and antidepressants as first-line treatments for neuropathic pain, including phantom limb pain, with opioids relegated to second-line status 1
Gabapentin and pregabalin work by binding to the α-2-δ subunit of voltage-gated calcium channels, reducing neuropathic pain transmission 2
Secondary amine tricyclic antidepressants, such as nortriptyline, are preferred over tertiary amines due to fewer anticholinergic side effects, with a starting dose of 10 mg/day in older adults and titration to a maximum of 75 mg/day 3
SNRIs, such as duloxetine, offer similar efficacy with fewer anticholinergic effects and no ECG monitoring requirement, with a dose of 60 mg once daily 3

Initiate monotherapy with either gabapentin or a secondary amine TCA, selecting based on comorbidities, and allow adequate trial duration of at least 2 weeks at therapeutic doses before assessing efficacy 3
If partial response occurs, add another first-line agent from a different class, rather than switching, as combination therapy may provide additive benefits 2

Inadequate dosing is a frequent cause of treatment failure, with gabapentin requiring at least 900 mg/day and preferably 1800-3600 mg/day for efficacy 3
Premature discontinuation before reaching therapeutic levels or adequate trial duration leads to false treatment failures 3
Excessive reliance on opioids should be avoided as first-line therapy due to dependency risks, cognitive impairment, and the fact that neuropathic pain is generally less opioid-responsive than nociceptive pain 3
Overlooking non-pharmacological approaches, such as transcutaneous electrical nerve stimulation (TENS), physical therapy, or interventional procedures, limits comprehensive management 3

In elderly patients, start all medications at lower doses and titrate more slowly to minimize adverse effects 3
Adjust gabapentinoid doses in patients with renal impairment 2
Use TCAs with extreme caution in patients with cardiac disease, limiting doses to less than 100 mg/day 2

Evidence shows that ketamine, gabapentin, or locoregional anesthesia techniques administered in the first 24 hours post-amputation do not prevent phantom limb pain development 4
Low-dose perioperative ketamine may reduce chronic pain risk after surgery generally, but this has not been specifically demonstrated for phantom limb pain prevention 4

Capsaicin 0.025-0.075% cream applied 3-4 times daily for 6 weeks may help reduce phantom limb pain, though initial burning sensations occur, as reported by the Mayo Clinic Proceedings 5
Tramadol and tapentadol, centrally acting opioid analgesics with SNRI properties, are probably effective for phantom limb pain but carry similar addiction risks, according to Diabetes Care 6
Gabapentinoid adverse effects may be more severe in older individuals but can be attenuated by lower starting doses and gradual titration, as noted in Diabetes Care 6

No non-pharmacological interventions with associated citations were found in the article.

Phantom limb pain represents a model for denervation pain resulting from exaggerated input from the dorsal root ganglia that used to innervate the limb 7

Transcutaneous electrical nerve stimulation (TENS) and physical therapy should be incorporated as part of comprehensive management, although the evidence is not provided here, it is generally recommended by the American Academy of Physical Medicine and Rehabilitation 7
Cognitive behavioral therapy helps address psychological aspects of chronic pain, as suggested by the American Psychological Association 7

The pathophysiological rationale for DRG stimulation is that phantom limb pain results from exaggerated input from dorsal root ganglia that previously innervated the limb, making DRG the logical therapeutic target 8
The American Society of Anesthesiologists recommends spinal cord stimulation for postamputation pain as part of multimodal care, and transcutaneous electrical nerve stimulation should be incorporated as part of multimodal management for phantom limb pain 9

The American Society of Anesthesiologists suggests that spinal cord stimulation provides less precise paresthesia coverage and more postural instability compared to DRG stimulation, although it is still an option for phantom limb pain 9